NCT04332874 2026-01-30A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or LegMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting30 enrolled